These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 17142134)

  • 21. The angiotensin II receptor antagonist valsartan enhances lipoprotein lipase mass in preheparin serum in type 2 diabetes with hypertension.
    Saiki A; Ohira M; Endo K; Koide N; Oyama T; Murano T; Miyashita Y; Shirai K
    Diabetes Res Clin Pract; 2006 Dec; 74(3):242-8. PubMed ID: 16713009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin II receptor blockade with valsartan decreases plasma osteopontin levels in patients with essential hypertension.
    Kurata M; Okura T; Irita J; Enomoto D; Nagao T; Jotoku M; Miyoshi K; Desilva VR; Higaki J
    J Hum Hypertens; 2011 May; 25(5):334-9. PubMed ID: 20664555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bradykinin B(2) receptor does not contribute to blood pressure lowering during AT(1) receptor blockade.
    LeFebvre J; Shintani A; Gebretsadik T; Petro JR; Murphey LJ; Brown NJ
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1261-7. PubMed ID: 17182977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the angiotensin II type 1 receptor antagonist valsartan on the expression of superoxide dismutase in hypertensive patients.
    Yang HY; Kao PF; Chen TH; Tomlinson B; Ko WC; Chan P
    J Clin Pharmacol; 2007 Mar; 47(3):397-403. PubMed ID: 17322151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing antihypertensive effect and plasma ciclosporin concentration between amlodipine and valsartan regimens in hypertensive renal transplant patients receiving ciclosporin therapy.
    Cai J; Huang Z; Yang G; Cheng K; Ye Q; Ming Y; Zuo X; Zhou P; Yuan H
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):401-9. PubMed ID: 22149319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
    Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Caloric restriction decreases age-dependent accumulation of the glycoxidation products, N epsilon-(carboxymethyl)lysine and pentosidine, in rat skin collagen.
    Cefalu WT; Bell-Farrow AD; Wang ZQ; Sonntag WE; Fu MX; Baynes JW; Thorpe SR
    J Gerontol A Biol Sci Med Sci; 1995 Nov; 50(6):B337-41. PubMed ID: 7583789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of valsartan and indapamide on plasma cytokines in essential hypertension.
    Xie QY; Wang YJ; Sun ZL; Yang TL
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):629-34. PubMed ID: 17062919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prospective, randomized, open-label trial comparing telmisartan 80 mg with valsartan 80 mg in patients with mild to moderate hypertension using ambulatory blood pressure monitoring.
    Littlejohn T; Mroczek W; Marbury T; VanderMaelen CP; Dubiel RF
    Can J Cardiol; 2000 Sep; 16(9):1123-32. PubMed ID: 11021956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implication of altered redox regulation by antioxidant enzymes in the increased plasma pentosidine, an advanced glycation end product, in uremia.
    Ueda Y; Miyata T; Hashimoto T; Yamada H; Izuhara Y; Sakai H; Kurokawa K
    Biochem Biophys Res Commun; 1998 Apr; 245(3):785-90. PubMed ID: 9588192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Valsartan therapy has additive anti-oxidative effect to that of fluvastatin therapy against low-density lipoprotein oxidation: studies in hypercholesterolemic and hypertensive patients.
    Hussein O; Shneider J; Rosenblat M; Aviram M
    J Cardiovasc Pharmacol; 2002 Jul; 40(1):28-34. PubMed ID: 12072574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New biomarkers of Maillard reaction damage to proteins.
    Wells-Knecht KJ; Brinkmann E; Wells-Knecht MC; Litchfield JE; Ahmed MU; Reddy S; Zyzak DV; Thorpe SR; Baynes JW
    Nephrol Dial Transplant; 1996; 11 Suppl 5():41-7. PubMed ID: 9044306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma Levels of Pentosidine, Carboxymethyl-Lysine, Soluble Receptor for Advanced Glycation End Products, and Metabolic Syndrome: The Metformin Effect.
    Haddad M; Knani I; Bouzidi H; Berriche O; Hammami M; Kerkeni M
    Dis Markers; 2016; 2016():6248264. PubMed ID: 27829696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Preclinical and clinical profile of Valsartan, a selective angiotensin II type-1 receptor blocker].
    Kimura M; Mitani H; Isomura Y
    Nihon Yakurigaku Zasshi; 2002 Nov; 120(5):353-60. PubMed ID: 12491811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of smoking on risk factors for cardiovascular disease in patients with diabetes mellitus and renal insufficiency.
    Schiel R; Franke S; Busch M; Müller A; Fleck C; Müller UA; Braun A; Stein G
    Eur J Med Res; 2003 Jul; 8(7):283-91. PubMed ID: 12911864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients.
    Savoia C; Touyz RM; Volpe M; Schiffrin EL
    Hypertension; 2007 Feb; 49(2):341-6. PubMed ID: 17159079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transition metal-catalyzed oxidation of ascorbate in human cataract extracts: possible role of advanced glycation end products.
    Saxena P; Saxena AK; Cui XL; Obrenovich M; Gudipaty K; Monnier VM
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1473-81. PubMed ID: 10798665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: is there oxidative stress in uremia?
    Miyata T; Fu MX; Kurokawa K; van Ypersele de Strihou C; Thorpe SR; Baynes JW
    Kidney Int; 1998 Oct; 54(4):1290-5. PubMed ID: 9767546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of valsartan, hydrochlorothiazide, and their combination on 24-h ambulatory blood pressure response in elderly patients with systolic hypertension: a ValVET substudy.
    Duprez DA; Weintraub HS; Cushman WC; Purkayastha D; Zappe D; Samuel R; Izzo JL
    Blood Press Monit; 2011 Aug; 16(4):186-96. PubMed ID: 21747241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.